Labcorp : Corporate Responsibility Report (2001700-0326-1 BRO Corporate%20responsibility%20report%202025 FINAL)
LH
Published on 05/01/2026 at 03:57 pm EDT
2025 LABC ORP C ORPOR ATE RESPONSIBILIT Y REPOR T
today and tomorrow
Our company
OUR COMPANY
5 Our mission and values
Corporate responsibility strategy and oversight
Double materiality assessment
Governance
Enterprise risk management
Compliance
13 Supplier engagement and oversight
13 Enterprise Third-Party Risk Management (ETPRM)
14 Advancing privacy and security
OUR PEOPLE
16 Workforce demographics
17 Talent initiatives
19 Enhancing the employee experience
19 Rewarding our teams
20 Employee well-being
21 Developing our teams
Our people Our operations Our community Appendix
OUR OPER ATIONS
23 Enhancing our sustainability impact
24 Sustainability highlights
30 Environmental sustainability data
32 Keeping our teams safe
33 Business resilience planning
34 Animal care and welfare
35 Decentralized clinical trial (DCT) and patient centricity
OUR COMMUNIT Y
38 Supporting communities in times of crisis
39 Employees in action supporting our communities
40 The Labcorp Charitable Foundation
APPENDIX
43 Independent limited assurance report
44 Global Reporting Initiative (GRI)
47 Sustainability Accounting Standards Board (SASB)
48 U.N. Global Compact Ten Principles
48 Task Force on Climate-Related Financial Disclosures (TCFD)
51 EEO-1 Report
52 Cautionary statement regarding forward-looking statements
A message from Labcorp's Chairman and CEO
Guided by our mission to improve health and improve lives, Labcorp believes that science and technology have the power to transform lives. As a global leader in life sciences and healthcare, we recognize the important role we play in advancing health, fueling innovation and earning the trust of patients, customers, partners and communities around the world. Our responsibility extends beyond what we deliver to how we operate-through ethical leadership, environmental stewardship, sustainability and a deep commitment to our employees and communities.
In 2025, we achieved strong growth by continuing to grow relationships with health systems and regional/local laboratories; launching more than 130 innovative tests, including advancements in oncology, neurology, autoimmune disease and women's health; and enhancing our genetics capabilities through the successful integration of Invitae. Our recent launch of the first FDA-cleared blood test for Alzheimer's disease assessment in primary care settings and expanded access to MRD testing for various stages of breast, small cell lung cancer and stage III colon cancer help patients get answers sooner and enable timely care.
Our Diagnostics Laboratories business continues to be widely recognized for its extensive portfolio of routine and specialty tests that support a patient's entire health journey -from screening, to diagnosis, treatment selection and monitoring disease progression.
Additionally, our Biopharma Laboratory Services business is well known as a leader in drug development and provided support for more than 85% of the new drugs and therapeutic products approved by the U.S. Food and Drug Administration (FDA) in 2025.
As individuals increasingly take charge of their own health journeys, we broadened our consumer health offerings, expanding the testing solutions offered through Labcorp OnDemand and improving the Ovia by Labcorp app experience. We also accelerated innovation through artificial intelligence (AI) tools and digital platforms like Test Finder, which enables healthcare providers to find relevant diagnostic tests using plain language, saving time and improving accuracy. Additionally, our Global Trial Connect digital solution accelerates clinical trials by enhancing site workflows, improving startup efficiency and increasing patient recruitment. These and other automation platforms across our lab networks are enhancing quality, speed and customer experience.
As we grow, we also continue to embrace the tremendous opportunity we have to make a meaningful impact by operating responsibly for the good of our employees, patients, investors and the communities we serve.
In 2025, we advanced our sustainability strategy, made continued progress toward our Science Based Targets, expanded hybrid/electric vehicles across our fleet and increased investments in more energy-efficient facilities.
Through the Labcorp Charitable Foundation, we awarded more than 190 grants in 2025, supporting a range of initiatives including those addressing food insecurity and healthcare access for vulnerable populations, as well as advancing medical research and science, technology, engineering and math (STEM) education. For example, the Foundation's partnership with Project HOPE expanded breast cancer screening for uninsured populations in North Carolina and strengthened pediatric oncology services for rural communities in China.
Our employees are the foundation of everything we do, and this year we deepened our focus on their well-being and development. Through our Labcorp Education Advantage program, 3,900 employees received financial assistance to earn degrees that will help position them for career growth and advancement. We also launched a Cytology master's degree program to help address a critical educational and talent gap.
Looking ahead, we remain dedicated to operating responsibly, innovating with purpose and working together with our partners to advance health-today and tomorrow.
Adam H. Schechter
Chairman and Chief Executive Officer
Our company
Our people
Our operations
Our community
Appendix
Our company Our people Our operations Our community Appendix
5 Our mission and values
Corporate responsibility strategy and oversight
Double materiality assessment
Governance
Enterprise risk management
Compliance
13 Supplier engagement and oversight
13 Enterprise Third-Party Risk Management (ETPRM)
14 Advancing privacy and security
3 | 2025 LABCORP CORPORATE RESPONSIBILITY REPORT
Our company
Our people Our operations Our community Appendix
Our mission and values
Corporate responsibility strategy and oversight
Double materiality assessment
Governance
Enterprise risk management
Compliance
Supplier engagement and oversight
Enterprise Third-Party Risk Management (ETPRM)
Advancing privacy and security
Awards and recognition
We have the honor of being recognized as a top company and workplace by some of the world's most influential publications and organizations. These accolades and insights validate the hard work of our exceptional team, help attract and retain top talent and inspire us to improve. By committing to excellence, we hope to create an environment where the brightest minds can thrive and make meaningful contributions to global health.
Some of the awards and recognitions we received in 2025 include:
4 | 2025 LABCORP CORPORATE RESPONSIBILITY REPORT
Our mission Corporate Responsibility Double materiality Enterprise risk Supplier oversight and Enterprise Third-Party Risk Advancing privacy and values strategy and oversight assessment Governance management Compliance business diversity program Management (ETRPM) and security
Our people Our operations Our community Appendix
Our company
Our mission and values
Double materiality assessment
Our company
Corporate responsibility strategy and oversight
Our people Our operations Our community Appendix
Our mission and values
Governance
Enterprise risk management
Compliance
Supplier engagement and oversight
Enterprise Third-Party Risk Management (ETPRM)
Advancing privacy and security
Mission and values
At Labcorp, our mission is clear:
to improve health and improve lives.
Grounded in this commitment, we're advancing health today and tomorrow.
As a global leader in laboratory services, we help address many of society's most critical health challenges every day. We provide essential insights across oncology, women's health, autoimmune
disease, neurology and other complex conditions to guide detection, treatment and ongoing care. We put people at the center-making healthcare more accessible for individuals while empowering clinicians with actionable information. And through data and technology integration and close collaboration with pharmaceutical companies, researchers and health systems, we accelerate innovative therapies and precision diagnostics.
Our five Core Values serve as the foundation of our culture. These values guide how we work together and are the foundation of our success.
Mission Driven - Uphold our mission in everything we do, ensuring the highest ethics and integrity
Customer Centered - Drive customer success through tailored solutions and valuable experiences
Innovative - Lead with science, technology and innovation
Agile - Stay curious, anticipate change and adapt with a sense of urgency
Operationally Excellent - Operate efficiently while delivering exceptional quality at scale
5 | 2025 LABCORP CORPORATE RESPONSIBILITY REPORT
Md
1
Mission Driven
Cc
2
Customer Centered
In
3
Innovative
4
Agile
Ag
Oe
5
Operationally Excellent
Our mission and values
Our company
Our people Our operations Our community Appendix
Our mission and values
Corporate responsibility strategy and oversight
Double materiality assessment
Governance
Enterprise risk management
Compliance
Supplier engagement and oversight
Enterprise Third-Party Risk Management (ETPRM)
Advancing privacy and security
Our mission Improve health, improve lives
$14 billion
FY25 revenue
2025 LABCORP AT A GLANCE
~71,000
mission-driven employees
~175 million
patient interactions
~100 countries
served globally
130+
new tests launched in 2025
6 | 2025 LABCORP CORPORATE RESPONSIBILITY REPORT
85%+
of the new drugs and products approved by the U.S. FDA included Labcorp support
Our mission Corporate Responsibility Double materiality Enterprise risk Supplier oversight and Enterprise Third-Party Risk Advancing privacy and values strategy and oversight assessment Governance management Compliance business diversity program Management (ETRPM) and security
Our people Our operations Our community Appendix
Our company
Corporate responsibility strategy and oversight
Corporate responsibility strategy and oversight
Driven by our mission to improve health and improve lives, Labcorp champions sustainable operations and expanding access to healthcare. By embedding responsible practices at every level of our organization and innovating to make quality healthcare increasingly accessible, we're not just supporting our employees, customers, patients and communities-we're empowering them. As a trusted leader in healthcare, Labcorp aims to be a catalyst for positive change across the globe through our commitment to environmental stewardship and social responsibility.
Labcorp's corporate responsibility strategy is guided by the Corporate Responsibility Executive Steering Committee (ESC). This cross-functional group, comprising executive and senior leaders, collaborates with leadership and the Board to shape corporate responsibility strategy, advise on policies and oversee disclosures. The ESC reviews performance in areas such as sustainability, employee well-being and corporate responsibility, providing leadership and accountability for corporate responsibility goals. Labcorp has also designated a Chief Sustainability Officer who is supported by a dedicated sustainability team.
7 | 2025 LABCORP CORPORATE RESPONSIBILITY REPORT
Our people
Our operations
Our community
Appendix
Advancing privacy and security
Enterprise Third-Party Risk Management (ETPRM)
Supplier engagement and oversight
Compliance
Enterprise risk management
Governance
Double materiality assessment
Our mission and values
Corporate responsibility strategy and oversight
Our company
Double materiality assessment
Evolving Labcorp's reporting transparency and disclosures: Double materiality assessment
As a global provider of laboratory services, we seek to advance our corporate responsibility efforts by transparently addressing key corporate responsibility topics that impact our business. To support these efforts, in 2025, Labcorp conducted a double materiality assessment to evaluate sustainability matters from both financial and impact perspectives, to consider potential financial effects on the company's performance as well as impacts on the economy, people and the environment. This comprehensive approach allowed Labcorp to identify and prioritize sustainability matters that are significant to both our business operations and our broader stakeholder community. This assessment engaged stakeholders to collect diverse insights and comprehensively evaluate key areas of importance, enhancing our resilience to evolving regulatory requirements and informing our approach to sustainability.
Our double materiality assessment is aligned to established reputable standards, including European Sustainability Reporting Standards (ESRS 1), European Financial Reporting Advisory Group (EFRAG) Implementation Guide and the Corporate Sustainability Reporting Directive (CSRD).
Over 100 ESRS 1 topics were reviewed, identifying 80+ impacts, risks and opportunities relevant to Labcorp's global operations and assessed across different timeframes.
The material topics to Labcorp have been identified as:
Topics
Details
ESRS E1 - Climate change
Business Continuity Planning
Investment in Climate Adaptation
Operational Resilience
Renewable Energy Transition
ESRS E5-Resource use and circular economy
Biohazardous Waste Reduction
ESRS G1 - Business conduct
AI Governance
Animal Welfare
Compliance Programs
Corporate Culture
Corporate Social Responsibility
Cybersecurity
Lobbying and Policy Engagement
Management of Suppliers
ESRS S1 - Own workforce
AI Integration
Employee Engagement
Inclusion
Talent Attraction and Retention
Training and Career Development
Work-life Balance
Workplace Safety
ESRS S4 - Consumers and end-users
Access to Products and Services
Access to Quality Information
Clinical Trial Diversity
Data Privacy and Integrity
Health and Safety
By focusing on these material topics, Labcorp can maintain its commitment to corporate responsibility in alignment with regulatory standards while effectively managing risks and opportunities.
Our people
Our operations
Our community
Appendix
Advancing privacy and security
Enterprise Third-Party Risk Management (ETPRM)
Supplier engagement and oversight
Compliance
Enterprise risk management
Governance
Corporate responsibility strategy and oversight
Our mission and values
Double materiality assessment
Our company
Governance
The Labcorp Board of Directors is fundamental to our governance approach. Our Board members bring a strong balance of skills, experiences, backgrounds and expertise that demonstrates our commitment to a governance structure that reflects our employees, our customers and the communities that we serve.
LABCORP BOARD OF DIRECTORS
Adam H. Schechter Chairman, President and Chief Executive Officer, Labcorp Holdings Inc.
Kerrii B. Anderson Former Chief Executive Officer, Wendy's International, Inc.
Audit Committee, Nominating and Corporate Governance Committee
Victor Bulto President, Novartis US Audit Committee
Jeffrey A. Davis Former Chief Financial Officer, Dollar Tree, Inc.
Chair, Audit Committee
Quality and Compliance Committee
Kirsten M. Kliphouse Former President, Google Cloud Americas
Audit Committee
Garheng Kong, MD, PhD Managing Partner, HealthQuest Capital
Lead Independent Director Compensation and Human Capital Committee
Chair, Nominating and Corporate Governance Committee
Peter M. Neupert
Former Operating Partner, Health Evolution
Partners Inc.
Nominating and Corporate Governance Committee
Richelle P. Parham Former President of Global E-Commerce and Business Development, Universal
Music Group
Chair, Compensation and Human Capital Committee
Nominating and Corporate Governance Committee
Paul B. Rothman, MD Former Dean of the Medical Faculty for Johns Hopkins University School of
Medicine and Former Chief Executive Officer of Johns Hopkins Medicine
Compensation and Human Capital Committee
Chair, Quality and Compliance Committee
John H. Sampson, MD, PhD Vice Chancellor and Dean, University of Colorado Anschutz School of
Medicine, President of CU Medicine
Quality and Compliance Committee
Kathryn E. Wengel Executive Vice President, Chief Technical Operations & Risk Officer, Executive
Committee Member, Johnson & Johnson
Compensation and Human Capital Committee
Quality and Compliance Committee
Our people
Our operations
Our community
Appendix
Advancing privacy and security
Enterprise Third-Party Risk Management (ETPRM)
Supplier engagement and oversight
Compliance
Enterprise risk management
Double materiality assessment
Corporate responsibility strategy and oversight
Our mission and values
Governance
Our company
LABCORP BOARD OF DIRECTORS DEMOGRAPHICS
Directors
Director Diversity
The following charts provide information on the expected composition of the directors on our Board if the current nominees are elected at the 2026 Annual Meeting.
91%
Independent
64%
Diverse*
Director tenure
0-5 years
6-12 years
≥13 years
5
2
4
Director age
≤ 60 years of age 61-70 years of age
6
5
Learn more about corporate governance atLabcorp
* Ethnic/racial and gender diversity
Enterprise risk management
Enterprise risk management
Labcorp maintains an enterprise risk management (ERM) program designed to promote a culture of risk awareness and supported by a structured, ongoing process for identifying, assessing and managing risks across the company. The ERM program is intended to support effective reporting and oversight of key risks, while helping protect the company's reputation. The Labcorp Board of Directors annually reviews the ERM process, and management and designated risk process owners evaluate risks using a consistent methodology that considers impact, likelihood and control effectiveness.
Labcorp aligns its ERM activities with Internal Audit and leverages technology-enabled tools and external risk benchmarking to support risk visibility, as the company works to remain responsive to emerging trends and operational considerations.
Our people
Our operations
Our community
Appendix
Advancing privacy and security
Enterprise Third-Party Risk Management (ETPRM)
Supplier engagement and oversight
Compliance
Governance
Double materiality assessment
Corporate responsibility strategy and oversight
Our mission and values
Enterprise risk management
Our company
Compliance
Compliance program
In 2025, training highlights included:
Average employee completion rate across all compliance trainings
91%
Average employee completion rate for privacy trainings
91%
Learn more about Labcorp's compliance program and review our policies: Labcorp's Commitment to Ethics and Compliance.
Integrity is at the heart of everything we do, and our ethical practices earn us the trust of patients and customers around the globe. Labcorp maintains a robust compliance program with clear and easily accessible written policies and guidelines. The Labcorp Code of Conduct & Ethics, publicly available in 10 languages, outlines the compliance principles and standards to which every employee, officer, director, agent, representative, consultant, vendor and contractor must adhere.
Our compliance program includes annual risk assessments and audits to enhance processes and aid in the identification and prioritization of
healthcare compliance and anti-corruption risks. The outcomes from risk assessments and audits are communicated to relevant stakeholders and senior leadership and remediation plans are promptly developed and monitored for timely completion.
A critical component of our compliance program is mandatory annual training for all employees. In addition, Labcorp encourages employees to actively contribute to a strong compliance culture by proactively voicing concerns, asking questions and reporting issues promptly. We encourage employees to first approach their leadership or corporate resources like the Compliance or Human Resources (HR) departments. We also provide an action line platform that provides for confidential and anonymous reporting through an online portal and call center that is operated by an independent third-party vendor available 24 hours a day, 365 days a year with interpreter services in 150 languages. Reports are investigated and monitored through to closure. In 2025, Labcorp received a median of 1.41 reports per 100 employees, which is in line with industry benchmarks.
Our people
Our operations
Our community
Appendix
Advancing privacy and security
Enterprise Third-Party Risk Management (ETPRM)
Supplier engagement and oversight
Enterprise risk management
Governance
Double materiality assessment
Corporate responsibility strategy and oversight
Our mission and values
Compliance
Our company
Promoting fundamental human rights and ethical labor practices
Labcorp has implemented robust policies, procedures and training designed to help prevent, detect and combat human exploitation including modern slavery, human trafficking, forced labor, unlawful child labor and sexual exploitation, as well as other unethical or illegal labor practices within our workforce and across our supply chain among our agents, vendors and subcontractors.
We are committed to upholding and promoting fundamental human rights throughout our operations and supply chain. Guided by the principles of the United Nations Global Compact, the International Labor Organization and the Organization for Economic Cooperation and Development, we maintain programs and policies that:
Provide fair and equitable wages, benefits and employment conditions in accordance with local laws
Recognize employees' right to freedom of association
Provide humane and safe working conditions
Support a work environment that is free from human and sexual trafficking, forced and bonded labor and unlawful child labor
Foster a workplace free of discrimination and harassment
Monitor for potential human rights concerns connected with the mining and trading of minerals subject to conflict-related risks
Please view all previously filed combatting modern slavery statements and our ethical labor and anti-human trafficking policy.
Anti-corruption
Our Business Practices Manual includes a comprehensive anti-bribery and anti-corruption policy that underscores Labcorp's commitment to preventing bribery and improper payments in all forms. The policy
provides clear guidance on identifying red flags and reporting suspicious activities. Recognizing the heightened risks posed by intermediaries,
we maintain a rigorous due diligence process to assess entities and individuals representing Labcorp in interactions with government officials. Labcorp also participates in the United Nations Global Compact and is committed to supporting its Ten Principles designed to promote operating with fundamental responsibilities in the areas of human rights, labor, environment and anti-corruption.
Please view our anti-bribery and anti-corruption policy.
Ethical artificial intelligence governance
Labcorp's Artificial Intelligence (AI) Ethics Board, comprising members from compliance, law, information technology, security, human resources, internal audit and other departments, is dedicated to identifying and mitigating ethical risks in the design, development and use of AI by Labcorp and our vendors and subcontractors. Guided by the Labcorp AI Code of Ethics, the Board supports and advances fairness, privacy, transparency, accountability and safety in AI applications, including those developed in-house and by third parties.
The AI Ethics Board reviews AI uses, establishes criteria for necessary evaluations and conducts periodic reassessments to ensure alignment with ethical standards. It also oversees the development of training programs, updates AI-related policies and assesses awareness among employees about ethical AI practices. By addressing AI ethical risks proactively, Labcorp demonstrates our commitment to responsible AI practices and builds trust in our technological advancements.
Our people
Our operations
Our community
Appendix
Advancing privacy and security
Enterprise Third-Party Risk Management (ETPRM)
Supplier engagement and oversight
Compliance
Enterprise risk management
Governance
Double materiality assessment
Corporate responsibility strategy and oversight
Our mission and values
Our company
Supplier engagement and oversight
Enterprise Third-Party Risk Management (ETPRM)
Supplier engagement and oversight
Given Labcorp's extensive global presence and the crucial role our services play in the healthcare system, we are dedicated to maintaining a resilient, responsible and sustainable supply chain.
We engage a broad range of vendors for various aspects of Labcorp's operations, including laboratory supplies, contracted and professional services, collection materials, and cleaning and facility management. In 2025, we did business
with approximately 1,000 suppliers, representing a diverse range of sizes and ownership. We seek to provide fair and open access to qualified suppliers through our bidding and procurement processes, consistent with applicable law.
Supplier Code of Conduct
At Labcorp, our Supplier Code of Conduct applies across all global operations, establishing a unified and comprehensive Supplier Sustainability Program (SSP).
The Labcorp Supplier Sustainability Governance Committee oversees the implementation and enforcement of the SSP, maintaining alignment with our ethical and sustainability commitments. We expect our strategic suppliers
to uphold the principles outlined in the Supplier Code of Conduct while our employees receive training to support their application.
To enhance accessibility, Labcorp has translated the Supplier Code of Conduct into 14 languages, emphasizing expectations regarding monitoring, reporting and environmental conscientiousness.
For additional insights into our supplier sustainability initiatives, visit our webpage for suppliers and vendors.
Enterprise Third-Party Risk Management (ETPRM)
At Labcorp, we recognize the importance of proactively managing potential risks arising from our relationships with third-party entities such as vendors, suppliers, contractors and partners. To address these risks, we have implemented a centrally managed program that employs a comprehensive approach to identify, assess, manage and monitor risks associated with external relationships.
Highlights of ETPRM:
Risk assessments based on industry best practices and frameworks, including:
Cybersecurity risks (data breaches, findings, governance programs)
Compliance risks (regulatory violations, anti-human trafficking, anti-corruption)
Data privacy risks (unauthorized access to information)
Resilience (business continuity, disaster recovery)
AI risks (safeguards and use case assessment)
Critical third parties are periodically reassessed
Leverage tools and services to track real-time changes in risk (security incidents)
Our people
Our operations
Our community
Appendix
Advancing privacy and security
Compliance
Enterprise risk management
Governance
Double materiality assessment
Corporate responsibility strategy and oversight
Our mission and values
Enterprise Third-Party Risk Management (ETPRM)
Supplier engagement and oversight
Our company
Advancing privacy and security
Cybersecurity
Protecting the information maintained by Labcorp about our patients, customers, colleagues and partners against external and internal threats is a priority. Accordingly, Labcorp maintains an enterprise-wide cybersecurity risk management program and invests in cybersecurity policies, control standards and control procedures, including risk assessment activities, security and event monitoring capabilities, an Incident Response plan and other detection, prevention and protection capabilities designed to monitor and mitigate external and
insider threats. Through its Office of Information Security within the Information Technology organization, we engage in a risk-based monitoring and assessment process that analyzes potential business impact of cybersecurity threats to our systems and data and assesses the effectiveness of the controls in place.
Labcorp has implemented a formal cybersecurity governance program aligned to elements of the NIST Cybersecurity Framework and the Secure Controls Framework. The governance program integrates controls from various regulations, standards and best practices and supports a structured approach to identifying, protecting against, detecting, responding
to and recovering from cybersecurity threats. Our program includes the evaluation of the cybersecurity posture of third-party suppliers and vendors that have access to Labcorp's data or information technology systems.
Additional information regarding our cybersecurity program is included in our 2025 Form 10-K.
Data privacy
Our privacy program has robust controls and processes governing the collection, use and disclosure of personal information in compliance with applicable laws. These laws include HIPAA, the European General Data Protection Regulation (GDPR) and other global, federal and state privacy laws in the jurisdictions where we do business.
Personal information held by Labcorp is subject to our policies and procedures that are based on established privacy principles, such as only accessing personal information where permitted, only using the minimum amount of personal information necessary and being transparent with how personal information is used. Additionally, we continually monitor for new legal and regulatory requirements on protecting personal information to maintain the effectiveness and maturity of our privacy program.
View Labcorp's privacy policies.
Our people
Our operations
Our community
Appendix
Advancing privacy and security
Enterprise Third-Party Risk Management (ETPRM)
Supplier engagement and oversight
Compliance
Enterprise risk management
Governance
Double materiality assessment
Corporate responsibility strategy and oversight
Our mission and values
Our company
Our people
Our company Our operations Our community Appendix
16 Workforce demographics
17 Talent initiatives
19 Enhancing the employee experience
19 Rewarding our teams
20 Employee well-being
21 Developing our teams
Our company Our people Our operations Our community Appendix
Workforce demographics
Workforce demographics
Talent initiatives
Enhancing the employee experience Rewarding our teams Employee well-being Developing our teams
INSIDE LABCORP
Workforce demographics
Our success hinges on our ability to attract, develop and retain a highly specialized and skilled global workforce. Our strong reputation within the health industry provides a significant advantage in attracting top talent.
2025 LABCORP WORKFORCE DATA AND GROWTH
Enterprise
Gender
North America
Gender
EMEA
Gender
APAC
Gender
71%
72%
56%
64%
29%
28%
44%
36%
GENDER
RACE & ETHNICITY
Nearly
71,000
global headcount
~2.6%
of our global workforce is
represented by collective bargaining agreements
87%
Workforce has grown
1.2%
year-over-year1
13,667
new hires outpacing our
voluntary attrition rates
13%
24%
47%
U.S.
Race & ethnicity
16%
3% 11%
employees
part-time
full-time employees
89%
5%
Global footprint of workforce
6%
North America EMEA
APAC
Global headcount supplemented by contingent labor, which does not exceed
8% of workforce
VOLUNTARY ATTRITION
23%
14%
Global voluntary attrition
28%
14%
U.S. voluntary attrition
4% 8%
18%
KEY
Female
Male
Black or African American Hispanic
Asian & Pacific Islander
White
Other People of Color
42%
77%
Values may not add up to 100 percent due to rounding.
1Includes a combination of organic growth and adding employees through acquisitions
Talent initiatives
Our people
Our company Our operations Our community Appendix
Enhancing the employee experience
Talent initiatives
Workforce demographics
Rewarding our teams
Employee well-being
Developing our teams
Talent and culture
photo of more with a group of employees
Our people are the foundation of our success, and their diverse backgrounds, perspectives and experiences enable us to innovate and serve the complex needs of patients and customers worldwide. We remain committed to fostering a culture where every team member feels valued, supported and equipped to grow. Through our Talent and Culture initiatives, we continue to strengthen inclusive leadership, enhance the overall team member experience and deepen our connection to the communities and patients we serve.
Highlights for 2025 include:
Accelerated leadership excellence by developing an enterprise-wide Leadership Framework that defines critical competencies and success profiles aligned to Labcorp's values-creating a foundation for talent development and leadership effectiveness
Expanded learning resources to support leaders and employees in better understanding and serving diverse and neurodiverse patient populations
Provided mental health resources to support employees and their families and Mental Health First Aid training for all people leaders to better support individual emotional wellbeing while at work
Strengthened acquisition integration experiences by connecting acquired teams with employee resources groups (ERGs) and inclusion resources early in transitions
Expanded listening strategies to support continuous improvement and cultural growth
Launched inclusion education for leaders, providing scalable, role-relevant learning on topics such as disability inclusion, psychological safety, structured hiring and belonging
Continued deployment of anti-harassment training to employees around the world
Expanded partnerships and outreach to improve outcomes and hiring experiences of veterans and individuals with disabilities
Provided opportunities for greater engagement between employees and management, including virtual and in-person global, business unit and function town halls, as well as personal interactions with front-line employees during visits to our facilities
Continued growth of our Employee Resource Groups
ERGs are created and led by employee volunteers, and each one is open to all employees, of any background. ERGs are important resources to foster cross-connections, encourage belonging, support career development and champion employee voices.
We proudly support nine ERGs:
Our ERGs continue to experience significant growth, expanding globally. We now have nine ERGs groups with 123 local chapters in eight countries, including the United States, Belgium, China, Switzerland, Germany, India, Singapore
and the United Kingdom. In 2025, more than 8,000 employees actively participated as ERG members. This continued year-over-year growth and engagement underscores our dedication to building connections and creating an environment where employees feel they belong.
Our company
Our operations
Our community
Appendix
Developing our teams
Employee well-being
Rewarding our teams
Enhancing the employee experience
Talent initiatives
Workforce demographics
Our people
Enhancing the employee experience
Rewarding our teams
Enhancing the employee experience
Employee experience is a cornerstone of organizational success, influencing engagement, innovation and performance. A thriving employee experience fosters well-being and a sense of belonging, which are vital to maintaining a high-performing organization.
Our Advance Together program helps us continuously listen, learn and act on employee feedback. Our approach includes regular surveys and feedback
opportunities at pivotal moments in the employee journey, enabling us to act on areas for improvement and drive meaningful, responsive changes to the work environment.
It reflects our commitment to encouraging and embracing open communication and enabling employees to feel heard and supported. Engagement, Inclusion and Belonging scores have improved year over year, reflecting progress in cultural initiatives and employee sentiment.
Based on feedback from our 2024 employee survey, recognition was an opportunity to enhance the employee experience. To address this feedback, early in 2025 we launched Impact, a global program designed to enhance employee engagement and recognize service milestones and impactful achievements.
During this first year, 443,000 acts of recognition awards were shared, including 193,000 monetary Impact Awards.
Rewarding our teams
We operate within a complex, global and dynamic healthcare industry. Recognizing the need to attract and retain top talent for sustained growth and success, we maintain comprehensive and flexible compensation and benefits programs. We actively monitor market activity and employee movement within and outside of the life sciences industry to maintain competitiveness. In 2025, we increased our minimum hourly wage for all U.S.-based, non-union employees to $17.75 per hour, representing a $20 million investment in our frontline workforce, who are essential to delivering on our commitment to patients and customers. We also awarded $103 million in annual merit increases to recognize our talent and foster competitive pay in the market.
Our company
Our operations
Our community
Appendix
Developing our teams
Employee well-being
Rewarding our teams
Enhancing the employee experience
Talent initiatives
Workforce demographics
Our people
Disclaimer
Labcorp Holdings Inc. published this content on May 01, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 01, 2026 at 19:56 UTC.